Literature DB >> 20647979

Type 2 diabetes and obesity in adults.

Catherine Whitmore1.   

Abstract

There are approximately 2.5 million people in the UK with diabetes; 85-95% of whom have type 2 diabetes. Type 2 diabetes mellitus is characterized by insulin resistance and impaired insulin secretion. As approximately 90% of people with type 2 diabetes are overweight or obese, obesity is seen as a significant contributory factor in its development. This article aims to examine some of the physiological mechanisms by which overweight and obesity contribute to the development of type 2 diabetes, and review some of the approaches to managing overweight and obesity in the person with established type 2 diabetes, including dietary management, the use of reduced carbohydrate diets on glycamic control, anti-diabetes and anti-obesity drugs both in use and in development, and bariatric surgery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20647979     DOI: 10.12968/bjon.2010.19.14.49041

Source DB:  PubMed          Journal:  Br J Nurs        ISSN: 0966-0461


  14 in total

Review 1.  Glucagon-like peptide-1 receptor agonists versus insulin glargine for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Wei-Xin Li; Jian-Feng Gou; Jin-Hui Tian; Xiang Yan; Lin Yang
Journal:  Curr Ther Res Clin Exp       Date:  2010-08

2.  Evaluation of the association between the ADRA2A genetic polymorphisms and type 2 diabetes in a Chinese Han population.

Authors:  Tianjie Li; Xilin Zhu; Xiaopan Wu; Jingyun Li; Liping Pan; Pengtao Li; Zhenhui Xin; Harvest F Gu; Ying Liu
Journal:  Genet Test Mol Biomarkers       Date:  2012-12

Review 3.  Caloric restriction and chronic inflammatory diseases.

Authors:  O A González; C Tobia; J L Ebersole; M J Novak
Journal:  Oral Dis       Date:  2011-07-13       Impact factor: 3.511

4.  Association between weight gain, obesity, and sleep duration: a large-scale 3-year cohort study.

Authors:  Daiki Kobayashi; Osamu Takahashi; Gautam A Deshpande; Takuro Shimbo; Tsuguya Fukui
Journal:  Sleep Breath       Date:  2011-09-03       Impact factor: 2.816

5.  High sleep duration variability is an independent risk factor for weight gain.

Authors:  Daiki Kobayashi; Osamu Takahashi; Takuro Shimbo; Tomoya Okubo; Hiroko Arioka; Tsuguya Fukui
Journal:  Sleep Breath       Date:  2012-02-22       Impact factor: 2.816

6.  Effect of neuromuscular electrical muscle stimulation on energy expenditure in healthy adults.

Authors:  Miao-Ju Hsu; Shun-Hwa Wei; Ya-Ju Chang
Journal:  Sensors (Basel)       Date:  2011-02-01       Impact factor: 3.576

7.  Glycemic control rate of T2DM outpatients in China: a multi-center survey.

Authors:  Rong Chen; Linong Ji; Liming Chen; Li Chen; Dehong Cai; Bo Feng; Hongyu Kuang; Hong Li; Yiming Li; Jing Liu; Zhongyan Shan; Zilin Sun; Haoming Tian; Zhangrong Xu; Yancheng Xu; Yuzhi Yang; Liyong Yang; Xuefeng Yu; Dalong Zhu; Dajin Zou
Journal:  Med Sci Monit       Date:  2015-05-19

8.  CYP24A1 exacerbated activity during diabetes contributes to kidney tubular apoptosis via caspase-3 increased expression and activation.

Authors:  Alexandre Tourigny; Frédrick Charbonneau; Paul Xing; Rania Boukrab; Guy Rousseau; René St-Arnaud; Marie-Luise Brezniceanu
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

9.  Screening for Diabetes Mellitus among Tuberculosis Patients: Findings from a Study at a Tertiary Hospital in Lusaka, Zambia.

Authors:  Sombo Fwoloshi; Lottie M Hachaambwa; Kaseya O Chiyeñu; Lameck Chirwa; Thijs W Hoffman; Owen Ngalamika; Sarah Lou Bailey
Journal:  Can J Infect Dis Med Microbiol       Date:  2018-03-06       Impact factor: 2.471

10.  Prevalence and factors associated with overweight and obesity among patients with type 2 diabetes mellitus in Uganda-a descriptive retrospective study.

Authors:  Salome Tino; Billy N Mayanja; Michael Charles Mubiru; Emmanuel Eling; Edward Ddumba; Pontiano Kaleebu; Moffat Nyirenda
Journal:  BMJ Open       Date:  2020-11-04       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.